$6.75 Billion is the total value of Eventide Asset Management's 156 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 35.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FIVN | Buy | FIVE9 INC | $184,273,000 | -9.6% | 1,178,742 | +0.8% | 2.73% | -12.7% |
| TTD | Buy | THE TRADE DESK INC | $178,767,000 | -17.9% | 274,325 | +1.0% | 2.65% | -20.6% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $137,725,000 | -9.9% | 2,015,000 | +13.0% | 2.04% | -12.9% |
| TWLO | Buy | TWILIO INCcl a | $133,609,000 | +0.9% | 392,090 | +0.3% | 1.98% | -2.5% |
| ROP | Buy | ROPER TECHNOLOGIES INC | $125,318,000 | -5.1% | 310,700 | +1.5% | 1.86% | -8.3% |
| LRCX | Buy | LAM RESEARCH CORP | $121,694,000 | +26.3% | 204,446 | +0.2% | 1.80% | +22.0% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $116,753,000 | +27.5% | 971,077 | +7.8% | 1.73% | +23.2% |
| FVRR | Buy | FIVERR INTL LTD | $115,445,000 | +12.3% | 531,562 | +0.9% | 1.71% | +8.5% |
| TT | Buy | TRANE TECHNOLOGIES PLC | $102,780,000 | +16.6% | 620,800 | +2.3% | 1.52% | +12.7% |
| NEP | Buy | NEXTERA ENERGY PARTNERS LP | $98,322,000 | +9.8% | 1,349,100 | +1.0% | 1.46% | +6.1% |
| ZI | Buy | ZOOMINFO TECHNOLOGIES INC | $95,225,000 | +4.0% | 1,947,351 | +2.6% | 1.41% | +0.5% |
| DHI | Buy | D R HORTON INC | $94,725,000 | +80.9% | 1,062,893 | +39.9% | 1.40% | +74.8% |
| ODFL | Buy | OLD DOMINION FREIGHT LINE IN | $91,136,000 | +28.3% | 379,085 | +4.1% | 1.35% | +24.1% |
| CTAS | Buy | CINTAS CORP | $83,348,000 | +31.7% | 244,200 | +36.4% | 1.24% | +27.3% |
| Buy | TRILLIUM THERAPEUTICS INC | $82,258,000 | +17.0% | 7,659,000 | +60.2% | 1.22% | +13.0% | |
| GNRC | Buy | GENERAC HLDGS INC | $75,052,000 | +130.8% | 229,200 | +60.3% | 1.11% | +122.8% |
| VRSK | Buy | VERISK ANALYTICS INC | $75,058,000 | -13.8% | 424,800 | +1.3% | 1.11% | -16.7% |
| MGA | Buy | MAGNA INTL INC | $74,658,000 | +31.3% | 848,000 | +5.6% | 1.11% | +26.8% |
| EPIX | Buy | ESSA PHARMA INC | $69,870,000 | +164.0% | 2,405,169 | +3.0% | 1.04% | +154.9% |
| ENTG | Buy | ENTEGRIS INC | $68,880,000 | +823.3% | 616,099 | +693.6% | 1.02% | +795.6% |
| RNG | Buy | RINGCENTRAL INCcl a | $65,864,000 | -19.5% | 221,108 | +2.4% | 0.98% | -22.2% |
| VITL | Buy | VITAL FARMS INC | $65,700,000 | +26.4% | 3,008,232 | +46.5% | 0.97% | +22.2% |
| RXDX | New | PROMETHEUS BIOSCIENCES INC | $65,568,000 | – | 3,714,032 | +100.0% | 0.97% | – |
| ARGX | Buy | ARGENX SEsponsored adr | $58,933,000 | +25.2% | 214,000 | +33.8% | 0.87% | +20.9% |
| CCI | Buy | CROWN CASTLE INTL CORP NEW | $54,049,000 | +22.4% | 314,000 | +13.2% | 0.80% | +18.3% |
| TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $53,593,000 | +1805.2% | 453,100 | +1656.2% | 0.79% | +1746.5% |
| CGEM | New | CULLINAN ONCOLOGY INC | $49,025,000 | – | 1,212,555 | +100.0% | 0.73% | – |
| PANW | Buy | PALO ALTO NETWORKS INC | $48,063,000 | -8.9% | 149,237 | +0.5% | 0.71% | -12.0% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $46,097,000 | +36.2% | 474,000 | +34.3% | 0.68% | +31.6% |
| BEPC | Buy | BROOKFIELD RENEWABLE CORPcl a sub vtg | $45,787,000 | +68.1% | 978,357 | +109.3% | 0.68% | +62.4% |
| KURA | Buy | KURA ONCOLOGY INC | $45,729,000 | +32.1% | 1,617,573 | +52.6% | 0.68% | +27.7% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $45,100,000 | +4.2% | 2,016,993 | +3.6% | 0.67% | +0.6% |
| ZYME | New | ZYMEWORKS INC | $44,147,000 | – | 1,397,954 | +100.0% | 0.65% | – |
| BBIO | New | BRIDGEBIO PHARMA INC | $43,871,000 | – | 712,197 | +100.0% | 0.65% | – |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $42,486,000 | +32.0% | 2,062,433 | +12.3% | 0.63% | +27.5% |
| IMVT | Buy | IMMUNOVANT INC | $39,667,000 | -7.9% | 2,473,000 | +165.3% | 0.59% | -10.9% |
| DDOG | Buy | DATADOG INC | $39,245,000 | -14.7% | 470,903 | +0.7% | 0.58% | -17.6% |
| NRIX | Buy | NURIX THERAPEUTICS INC | $37,308,000 | +8.1% | 1,200,000 | +14.3% | 0.55% | +4.5% |
| CWEN | Buy | CLEARWAY ENERGY INCcl c | $36,679,000 | -7.9% | 1,303,400 | +4.5% | 0.54% | -11.0% |
| MAX | Buy | MEDIAALPHA INCcl a | $36,654,000 | +1422.8% | 1,034,559 | +1579.2% | 0.54% | +1367.6% |
| ETNB | Buy | 89BIO INC | $30,039,000 | +41.8% | 1,268,539 | +46.0% | 0.44% | +36.9% |
| CCXI | Buy | CHEMOCENTRYX INC | $28,694,000 | +19.7% | 560,000 | +44.7% | 0.42% | +15.8% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $26,671,000 | +68.3% | 1,490,000 | +44.6% | 0.40% | +62.6% |
| KROS | Buy | KEROS THERAPEUTICS INC | $26,307,000 | +7.8% | 427,414 | +23.5% | 0.39% | +4.3% |
| MPWR | Buy | MONOLITHIC PWR SYS INC | $26,194,000 | -1.8% | 74,159 | +1.8% | 0.39% | -5.1% |
| BYND | New | BEYOND MEAT INC | $19,855,000 | – | 152,593 | +100.0% | 0.29% | – |
| BFLY | New | BUTTERFLY NETWORK INC | $18,816,000 | – | 1,118,000 | +100.0% | 0.28% | – |
| FRC | Buy | FIRST REP BK SAN FRANCISCO C | $16,542,000 | +75.1% | 99,200 | +54.3% | 0.24% | +69.0% |
| CRDF | New | CARDIFF ONCOLOGY INC | $16,515,000 | – | 1,783,488 | +100.0% | 0.24% | – |
| SBTX | Buy | SILVERBACK THERAPEUTICS INC | $16,203,000 | +2.4% | 371,384 | +8.8% | 0.24% | -1.2% |
| CIEN | Buy | CIENA CORP | $15,769,000 | +11.7% | 288,175 | +7.9% | 0.23% | +8.3% |
| A | Buy | AGILENT TECHNOLOGIES INC | $15,727,000 | +43.5% | 123,700 | +33.7% | 0.23% | +38.7% |
| FHN | Buy | FIRST HORIZON CORPORATION | $14,691,000 | +66.0% | 868,800 | +25.2% | 0.22% | +60.3% |
| PHVS | New | PHARVARIS N V | $14,030,000 | – | 500,000 | +100.0% | 0.21% | – |
| SHLS | New | SHOALS TECHNOLOGIES GROUP INcl a added | $13,654,000 | – | 392,556 | +100.0% | 0.20% | – |
| PLD | Buy | PROLOGIS INC. | $13,043,000 | +43.7% | 123,044 | +35.1% | 0.19% | +38.8% |
| STE | Buy | STERIS PLC | $12,876,000 | +114.6% | 67,600 | +113.6% | 0.19% | +107.6% |
| BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $12,302,000 | – | 411,838 | +100.0% | 0.18% | – |
| SNV | New | SYNOVUS FINL CORP | $12,165,000 | – | 265,900 | +100.0% | 0.18% | – |
| DSGN | New | DESIGN THERAPEUTICS INC | $11,960,000 | – | 400,000 | +100.0% | 0.18% | – |
| KLAC | Buy | KLA CORP | $11,828,000 | +79.2% | 35,798 | +40.4% | 0.18% | +73.3% |
| PNR | Buy | PENTAIR PLC | $11,137,000 | +109.6% | 178,700 | +78.5% | 0.16% | +103.7% |
| BOLT | New | BOLT BIOTHERAPEUTICS INC | $10,628,000 | – | 322,944 | +100.0% | 0.16% | – |
| SGFY | New | SIGNIFY HEALTH INC | $10,456,000 | – | 357,360 | +100.0% | 0.16% | – |
| SBNY | Buy | SIGNATURE BK NEW YORK N Y | $8,411,000 | +140.0% | 37,200 | +43.6% | 0.12% | +131.5% |
| IEX | Buy | IDEX CORP | $7,891,000 | +126.0% | 37,700 | +115.1% | 0.12% | +116.7% |
| Buy | PALO ALTO NETWORKS INCnote 0.750% 7/0 | $7,852,000 | +28.2% | 5,928,000 | +36.8% | 0.12% | +23.4% | |
| SNPS | Buy | SYNOPSYS INC | $6,927,000 | +54.4% | 27,957 | +61.5% | 0.10% | +49.3% |
| ALXO | New | ALX ONCOLOGY HLDGS INC | $6,637,000 | – | 90,000 | +100.0% | 0.10% | – |
| VFC | Buy | V F CORP | $6,521,000 | +223.5% | 81,600 | +245.8% | 0.10% | +212.9% |
| AWK | Buy | AMERICAN WTR WKS CO INC NEW | $6,462,000 | +45.7% | 43,100 | +49.1% | 0.10% | +41.2% |
| SBAC | Buy | SBA COMMUNICATIONS CORP NEWcl a | $6,319,000 | +28.2% | 22,766 | +30.3% | 0.09% | +23.7% |
| ARE | Buy | ALEXANDRIA REAL ESTATE EQ IN | $6,293,000 | +9.3% | 38,300 | +18.6% | 0.09% | +5.7% |
| ELS | New | EQUITY LIFESTYLE PPTYS INC | $6,065,000 | – | 95,300 | +100.0% | 0.09% | – |
| SLDB | New | SOLID BIOSCIENCES INC | $5,983,000 | – | 1,081,868 | +100.0% | 0.09% | – |
| SYY | Buy | SYSCO CORP | $5,858,000 | +43.4% | 74,400 | +35.3% | 0.09% | +38.1% |
| GRMN | Buy | GARMIN LTD | $5,643,000 | +125.6% | 42,800 | +104.8% | 0.08% | +121.1% |
| MSCI | Buy | MSCI INC | $4,696,000 | +47.1% | 11,200 | +56.6% | 0.07% | +42.9% |
| ZTS | Buy | ZOETIS INCcl a | $4,504,000 | +22.6% | 28,600 | +28.8% | 0.07% | +19.6% |
| New | RINGCENTRAL INCnote 3/0 | $4,336,000 | – | 3,940,000 | +100.0% | 0.06% | – | |
| NDAQ | Buy | NASDAQ INC | $3,952,000 | +58.3% | 26,800 | +42.6% | 0.06% | +55.3% |
| FOUR | Buy | SHIFT4 PMTS INCcl a | $3,786,000 | +57.6% | 46,160 | +44.9% | 0.06% | +51.4% |
| OLK | New | OLINK HLDG ABsponsored ads added | $3,636,000 | – | 101,000 | +100.0% | 0.05% | – |
| New | EXACT SCIENCES CORPnote 0.375% 3/0 | $2,720,000 | – | 2,100,000 | +100.0% | 0.04% | – | |
| LSCC | Buy | LATTICE SEMICONDUCTOR CORP | $2,631,000 | +64.3% | 58,447 | +67.3% | 0.04% | +56.0% |
| AMD | Buy | ADVANCED MICRO DEVICES INC | $2,377,000 | +26.3% | 30,285 | +47.6% | 0.04% | +20.7% |
| DBTX | New | DECIBEL THERAPEUTICS INC | $2,272,000 | – | 200,000 | +100.0% | 0.03% | – |
| OM | Buy | OUTSET MED INC | $1,971,000 | +32.2% | 36,237 | +38.1% | 0.03% | +26.1% |
| SLAB | Buy | SILICON LABORATORIES INC | $1,754,000 | +49.8% | 12,437 | +35.2% | 0.03% | +44.4% |
| TTD | New | THE TRADE DESK INCcall | $1,125,000 | – | 1,500 | +100.0% | 0.02% | – |
| PAYC | New | PAYCOM SOFTWARE INC | $925,000 | – | 2,500 | +100.0% | 0.01% | – |
| ONTF | New | ON24 INC | $654,000 | – | 13,478 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-14
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LOWES COS INC | 40 | Q3 2023 | 3.2% |
| PALO ALTO NETWORKS INC | 40 | Q3 2023 | 3.6% |
| ASML HOLDINGS NV | 40 | Q3 2023 | 1.9% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
| REPLIGEN CORP | 40 | Q3 2023 | 0.5% |
| VERACYTE INC | 38 | Q3 2023 | 1.5% |
| LAM RESEARCH CORP | 35 | Q3 2023 | 3.4% |
| XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.6% |
| MAGNA INTL INC | 33 | Q4 2021 | 2.5% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cogent Biosciences, Inc. | February 14, 2023 | 2,589,778 | 3.7% |
| ESSA Pharma Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Freeline Therapeutics Holdings plc | February 14, 2023 | 5,920,765 | 9.1% |
| KnowBe4, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Praxis Precision Medicines, Inc. | February 14, 2023 | 3,518,062 | 7.5% |
| Prometheus Biosciences, Inc. | February 14, 2023 | 1,032,938 | 2.2% |
| SUTRO BIOPHARMA, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Vital Farms, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Zymeworks Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Entasis Therapeutics Holdings Inc. | February 14, 2022 | 590,602 | 1.2% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.